Sequana Medical Investor Presentation 2022

Loading viewer...

investor_presentation

Format: PDF investor_presentation

Sequana Medical presented its investor deck in February 2022 detailing innovations in treating diuretic-resistant fluid overload. The presentation covers the alfapump® system for refractory ascites and DSR® therapy, both addressing critical unmet needs in fluid management.

Browse all investor_presentations →

Related tags

Your message matters.

Let us design a presentation that delivers.

Lets get started

More from Sequana Medical

View all →

Sequana Medical 2021 BioCapital Europe Presentation

investor_presentation

19 Pages

Sequana Medical 2021 H.C. Wainwright Global Investment Conference

conference

Similar investor_presentations from other companies

Browse all →

GMS Investor Presentation — April 2018

investor_presentation

20 Pages

GMS

Schaeffler AG 2021 Investor Presentation Q1 Americas

investor_presentation